Recent News

Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30
Program here.
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, .
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici.
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici.
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo.
Le CERIMED obtient la double certification ISO 9001:2015 et NF X50-900:2016 pour ses activités de prestation et d’innovation radiologiques et nucléaires pré-cliniques
Le Centre Européen de Recherche en Imagerie Médicale (CERIMED, UMS AMU CNRS 2012) a obtenu le 5 juin 2022 la double certification ISO 9001:2015 et NF-X50-900:2016 pour
Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”
Program here.
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility

Last Publications (10/376)

Verger, A, Cecchin, D, Guedj, E, Albert, NL, Brendel, M, Fraioli, F et al.. Correction to: EANM perspectives for CZT SPECT in brain applications. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06842-3. PubMed PMID:39017919 .
Bobot, M, Bruno, J, Burtey, S. Cognitive Impairment Phenotypes in Patients with CKD Stages 3b and 4. Kidney360. 2024;5 (6):787-788. doi: 10.34067/KID.0000000000000474. PubMed PMID:38935489 PubMed Central PMC11219103.
Brendel, M, Guedj, E, Yakushev, I, Morbelli, S, Höglinger, GU, Tolboom, N et al.. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06803-w. PubMed PMID:38907856 .
Bobot, M, Heim, X, Max, H, Boucraut, J, Simeone, P, Stein, C et al.. Prospective Multicenter Study on Early Proximal Tubular Injury in COVID-19-Related Acute Respiratory Distress Syndrome. Kidney Int Rep. 2024;9 (6):1641-1653. doi: 10.1016/j.ekir.2024.03.011. PubMed PMID:38899195 PubMed Central PMC11184390.
Albert, NL, Preusser, M, Traub-Weidinger, T, Tolboom, N, Law, I, Palmer, JD et al.. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06783-x. PubMed PMID:38898354 .
Horowitz, T, Dudouet, P, Campion, JY, Kaphan, E, Radulesco, T, Gonzalez, S et al.. Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [¹⁸F]FDG-PET study. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06775-x. PubMed PMID:38862619 .
Verger, A, Cecchin, D, Guedj, E, Albert, NL, Brendel, M, Fraioli, F et al.. EANM perspectives for CZT SPECT in brain applications. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06788-6. PubMed PMID:38858281 .
Varoquaux, A, Fakhry, N, Scemama, U, Taïeb, D. Differentiation of vagal from carotid paraganglioma on unenhanced PET/CT: the “sweet potato” shape on PET. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06776-w. PubMed PMID:38829375 .
Riviere, M, Brioude, G, Remond, V, Graille, I, Gaubert, JY, Habert, P et al.. [Imaging of actinomycosis: CT scan, bronchial embolization and pathology]. Rev Mal Respir. 2024;41 (6):446-450. doi: 10.1016/j.rmr.2024.05.002. PubMed PMID:38796385 .
Connell, E, Gerard, É, Oules, B, Brunet-Possenti, F, Lamoureux, A, Bonnefille, H et al.. Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma. Oncologist. 2024; :. doi: 10.1093/oncolo/oyae085. PubMed PMID:38761384 .

Search PubMed

Dernières Publications (10/376)

Verger, A, Cecchin, D, Guedj, E, Albert, NL, Brendel, M, Fraioli, F et al.. Correction to: EANM perspectives for CZT SPECT in brain applications. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06842-3. PubMed PMID:39017919 .
Bobot, M, Bruno, J, Burtey, S. Cognitive Impairment Phenotypes in Patients with CKD Stages 3b and 4. Kidney360. 2024;5 (6):787-788. doi: 10.34067/KID.0000000000000474. PubMed PMID:38935489 PubMed Central PMC11219103.
Brendel, M, Guedj, E, Yakushev, I, Morbelli, S, Höglinger, GU, Tolboom, N et al.. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06803-w. PubMed PMID:38907856 .
Bobot, M, Heim, X, Max, H, Boucraut, J, Simeone, P, Stein, C et al.. Prospective Multicenter Study on Early Proximal Tubular Injury in COVID-19-Related Acute Respiratory Distress Syndrome. Kidney Int Rep. 2024;9 (6):1641-1653. doi: 10.1016/j.ekir.2024.03.011. PubMed PMID:38899195 PubMed Central PMC11184390.
Albert, NL, Preusser, M, Traub-Weidinger, T, Tolboom, N, Law, I, Palmer, JD et al.. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06783-x. PubMed PMID:38898354 .
Horowitz, T, Dudouet, P, Campion, JY, Kaphan, E, Radulesco, T, Gonzalez, S et al.. Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [¹⁸F]FDG-PET study. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06775-x. PubMed PMID:38862619 .
Verger, A, Cecchin, D, Guedj, E, Albert, NL, Brendel, M, Fraioli, F et al.. EANM perspectives for CZT SPECT in brain applications. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06788-6. PubMed PMID:38858281 .
Varoquaux, A, Fakhry, N, Scemama, U, Taïeb, D. Differentiation of vagal from carotid paraganglioma on unenhanced PET/CT: the “sweet potato” shape on PET. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06776-w. PubMed PMID:38829375 .
Riviere, M, Brioude, G, Remond, V, Graille, I, Gaubert, JY, Habert, P et al.. [Imaging of actinomycosis: CT scan, bronchial embolization and pathology]. Rev Mal Respir. 2024;41 (6):446-450. doi: 10.1016/j.rmr.2024.05.002. PubMed PMID:38796385 .
Connell, E, Gerard, É, Oules, B, Brunet-Possenti, F, Lamoureux, A, Bonnefille, H et al.. Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma. Oncologist. 2024; :. doi: 10.1093/oncolo/oyae085. PubMed PMID:38761384 .

Search PubMed